Literature DB >> 1727677

A comparative cytopathologic and histologic study of atypia, dysplasia, and adenocarcinoma in Barrett's esophagus.

K R Geisinger1, L A Teot, J E Richter.   

Abstract

As a potentially premalignant condition, Barrett's esophagus has stimulated controversy over the need for surveillance of glandular dysplasia and early carcinoma. This prompted the authors to review their experience with endoscopic cytologic brushings and biopsies from patients with Barrett's esophagus. The authors reviewed 65 consecutive specimens from 42 patients with Barrett's esophagus in which both the concurrently obtained esophageal cytologic brushings and companion biopsy specimens were available. In addition, esophagogastrectomy specimens from 9 nine these patients were reviewed. Cytologic and histologic specimens were assigned to one of four diagnostic categories, based on specifically defined criteria: simple Barrett's esophagus with or without inflammatory atypia; dysplasia; adenocarcinoma; or suspicious for dysplasia or carcinoma. Simple Barrett's esophagus was diagnosed in 38 cytologic brushings and 44 biopsy specimens, dysplasia in 4 brushings and 7 biopsy specimens, and carcinoma in 14 brushings and 10 biopsy specimens. Nine brushings and three biopsy specimens were suspicious. In 13 cases, brushings revealed a higher grade lesion than did histology; in 5 cases, biopsy specimens showed a higher grade lesion. Agreement between the two occurred in 72% (47/65) of all specimens. Accuracy was confirmed in the histologic examinations of the resection specimens. The authors conclude that specific criteria, when consistently applied, allow accurate cytologic diagnoses of epithelial changes in Barrett's esophagus. The use of esophageal brush cytology and biopsy specimens provides two complementary techniques, which detect a greater number of serious lesions than either technique alone.

Entities:  

Mesh:

Year:  1992        PMID: 1727677     DOI: 10.1002/1097-0142(19920101)69:1<8::aid-cncr2820690105>3.0.co;2-q

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  8 in total

Review 1.  Barrett's oesophagus.

Authors:  R M Navaratnam; M C Winslet
Journal:  Postgrad Med J       Date:  1998-11       Impact factor: 2.401

2.  Automated cytological detection of Barrett's neoplasia with infrared spectroscopy.

Authors:  Oliver Old; Gavin Lloyd; Martin Isabelle; L Max Almond; Catherine Kendall; Karol Baxter; Neil Shepherd; Angela Shore; Nick Stone; Hugh Barr
Journal:  J Gastroenterol       Date:  2017-05-13       Impact factor: 7.527

3.  Cytological screening for Barrett's esophagus using a prototype flexible mesh catheter.

Authors:  A E Rader; D O Faigel; J Ditomasso; N Magaret; M Burm; M B Fennerty
Journal:  Dig Dis Sci       Date:  2001-12       Impact factor: 3.199

4.  Screening, surveillance, and prevention for esophageal cancer.

Authors:  Yutaka Tomizawa; Kenneth K Wang
Journal:  Gastroenterol Clin North Am       Date:  2009-03       Impact factor: 3.806

5.  A comparison of conventional cytology, DNA ploidy analysis, and fluorescence in situ hybridization for the detection of dysplasia and adenocarcinoma in patients with Barrett's esophagus.

Authors:  Emily G Barr Fritcher; Shannon M Brankley; Benjamin R Kipp; Jesse S Voss; Michael B Campion; Larry E Morrison; Mona S Legator; Lori S Lutzke; Kenneth K Wang; Thomas J Sebo; Kevin C Halling
Journal:  Hum Pathol       Date:  2008-07-07       Impact factor: 3.466

6.  Usefulness of endoscopic brushing and magnified endoscopy with narrow band imaging (ME-NBI) to detect intestinal phenotype in columnar-lined esophagus.

Authors:  Takahisa Murao; Akiko Shiotani; Yoshiyuki Yamanaka; Yoshiki Kimura; Hideaki Tsutsui; Hiroshi Matsumoto; Tomoari Kamada; Noriaki Manabe; Jiro Hata; Ken Haruma
Journal:  J Gastroenterol       Date:  2012-05-11       Impact factor: 7.527

Review 7.  Screening for Barrett's Esophagus.

Authors:  Massimiliano di Pietro; Daniel Chan; Rebecca C Fitzgerald; Kenneth K Wang
Journal:  Gastroenterology       Date:  2015-02-17       Impact factor: 22.682

8.  Combined EsophaCap cytology and MUC2 immunohistochemistry for screening of intestinal metaplasia, dysplasia and carcinoma.

Authors:  Zhongren Zhou; Irina Kalatskaya; Donna Russell; Norman Marcon; Maria Cirocco; Paul M Krzyzanowski; Cathy Streutker; Hua Liang; Virginia R Litle; Tony E Godfrey; Lincoln Stein
Journal:  Clin Exp Gastroenterol       Date:  2019-05-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.